{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:08:39Z","timestamp":1785150519296,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s40618-014-0215-1","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T14:56:52Z","timestamp":1417445812000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cardiovascular risk factors and events in women with androgen excess"],"prefix":"10.1007","volume":"38","author":[{"given":"D.","family":"Macut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. B.","family":"Anti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bjeki\u0107-Macut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,29]]},"reference":[{"key":"215_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez LA, Knochenhauer ES et al (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453\u2013462","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","volume":"91","author":"E Carmina","year":"2006","unstructured":"Carmina E, Rosato F, Janni A, Rizzo M, Longo RA (2006) Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91:2\u20136","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR3","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","volume":"84","author":"E Diamanti-Kandarakis","year":"1999","unstructured":"Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006\u20134011","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR4","first-page":"2434","volume":"85","author":"M Asuncion","year":"2000","unstructured":"Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434\u20132438","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/humrep\/des028","volume":"27","author":"R Sanchon","year":"2012","unstructured":"Sanchon R, Gambineri A, Alpanes M, Martinez-Garcia MA, Pasquali R, Escobar-Morreale HF (2012) Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Hum Reprod 27:1209\u20131216","journal-title":"Hum Reprod"},{"key":"215_CR6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1210\/jc.2009-1693","volume":"95","author":"GA Laughlin","year":"2010","unstructured":"Laughlin GA, Goodell V, Barrett-Connor E (2010) Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab 95:740\u2013747","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.08.037","volume":"204","author":"P Ouyang","year":"2009","unstructured":"Ouyang P, Vaidya D, Dobs A et al (2009) Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of atherosclerosis. Atherosclerosis 204:255\u2013261","journal-title":"Atherosclerosis"},{"key":"215_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.artres.2012.03.002","volume":"6","author":"KM M\u00e4ki-Pet\u00e4j\u00e4","year":"2012","unstructured":"M\u00e4ki-Pet\u00e4j\u00e4 KM, Wilkinson IB (2012) Inflammation and large arteries: potential mechanisms for inflammation-induced arterial stiffness potential mechanisms for inflammation-induced arterial stiffness. Artery Res 6:59\u201364","journal-title":"Artery Res"},{"key":"215_CR9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2012.07.005","volume":"224","author":"L Wang","year":"2012","unstructured":"Wang L, Szklo M, Folsom AR, Cook NR, Gapstur SM, Ouyang P (2012) Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 224:228\u2013234","journal-title":"Atherosclerosis"},{"key":"215_CR10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33:981\u20131030","journal-title":"Endocr Rev"},{"key":"215_CR11","first-page":"77","volume":"29","author":"JP Despres","year":"2006","unstructured":"Despres JP (2006) Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 29:77\u201382","journal-title":"J Endocrinol Invest"},{"key":"215_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","volume":"18","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP (2007) Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 18:280\u2013285","journal-title":"Trends Endocrinol Metab"},{"key":"215_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405\u2013413","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR14","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.2174\/1381612811319320011","volume":"19","author":"C Christakou","year":"2013","unstructured":"Christakou C, Diamanti-Kandarakis E (2013) Structural, biochemical and non-traditional cardiovascular risk markers in PCOS. Curr Pharm Des 19:5764\u20135774","journal-title":"Curr Pharm Des"},{"key":"215_CR15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","volume":"17","author":"KA Toulis","year":"2011","unstructured":"Toulis KA, Goulis DG, Mintziori G et al (2011) Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update 17:741\u2013760","journal-title":"Hum Reprod Update"},{"key":"215_CR16","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/humrep\/det119","volume":"28","author":"E Carmina","year":"2013","unstructured":"Carmina E, Campagna AM, Lobo RA (2013) Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors. Hum Reprod 28:2245\u20132252","journal-title":"Hum Reprod"},{"key":"215_CR17","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"LJ Shaw","year":"2008","unstructured":"Shaw LJ, Bairey Merz CN, Azziz R et al (2008) Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women\u2019s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93:1276\u20131284","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR18","first-page":"317","volume":"35","author":"Z Kurdoglu","year":"2012","unstructured":"Kurdoglu Z, Ozkol H, Tuluce Y, Koyuncu I (2012) Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome. J Endocrinol Invest 35:317\u2013321","journal-title":"J Endocrinol Invest"},{"key":"215_CR19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2362.2006.01712.x","volume":"36","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Alexandraki K, Piperi C et al (2006) Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest 36:691\u2013697","journal-title":"Eur J Clin Invest"},{"key":"215_CR20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","volume":"111","author":"RS Legro","year":"2001","unstructured":"Legro RS, Kunselman AR, Dunaif A (2001) Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607\u2013613","journal-title":"Am J Med"},{"key":"215_CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1139\/Y08-014","volume":"86","author":"D Macut","year":"2008","unstructured":"Macut D, Panidis D, Glisic B et al (2008) Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharmacol 86:199\u2013204","journal-title":"Can J Physiol Pharmacol"},{"key":"215_CR22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/aje\/154.6.489","volume":"154","author":"Y Liu","year":"2001","unstructured":"Liu Y, Ding J, Bush TL et al (2001) Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidemiol 154:489\u2013494","journal-title":"Am J Epidemiol"},{"key":"215_CR23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/BF03346706","volume":"34","author":"M Rizzo","year":"2011","unstructured":"Rizzo M, Longo RA, Guastella E, Rini GB, Carmina E (2011) Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome. J Endocrinol Invest 34:422\u2013426","journal-title":"J Endocrinol Invest"},{"key":"215_CR24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/eje.1.02187","volume":"155","author":"D Macut","year":"2006","unstructured":"Macut D, Damjanovic S, Panidis D et al (2006) Oxidised low-density lipoprotein concentration\u2014early marker of an altered lipid metabolism in young women with PCOS. Eur J Endocrinol 155:131\u2013136","journal-title":"Eur J Endocrinol"},{"key":"215_CR25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ecl.2011.01.009","volume":"40","author":"R Bentley-Lewis","year":"2011","unstructured":"Bentley-Lewis R, Seely E, Dunaif A (2011) Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am 40:433\u2013449 (ix\u2013x)","journal-title":"Endocrinol Metab Clin North Am"},{"key":"215_CR26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","volume":"17","author":"PC Groot de","year":"2011","unstructured":"de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM (2011) PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update 17:495\u2013500","journal-title":"Hum Reprod Update"},{"key":"215_CR27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/cen.12068","volume":"78","author":"H Mani","year":"2013","unstructured":"Mani H, Levy MJ, Davies MJ et al (2013) Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol (Oxf) 78:926\u2013934","journal-title":"Clin Endocrinol (Oxf)"},{"key":"215_CR28","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E et al (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 95:2038\u20132049","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 5","key":"215_CR29","first-page":"1353","volume":"14","author":"D Macut","year":"2001","unstructured":"Macut D, Micic D, Cvijovic G et al (2001) Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS). J Pediatr Endocrinol Metab 14(suppl 5):1353\u20131359 (discussion 1365)","journal-title":"J Pediatr Endocrinol Metab"},{"key":"215_CR30","first-page":"358","volume":"36","author":"E Carmina","year":"2013","unstructured":"Carmina E (2013) Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome. J Endocrinol Invest 36:358\u2013363","journal-title":"J Endocrinol Invest"},{"key":"215_CR31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0031-1279740","volume":"119","author":"D Macut","year":"2011","unstructured":"Macut D, Simic T, Lissounov A et al (2011) Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. Exp Clin Endocrinol Diabetes 119:451\u2013455","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"215_CR32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","volume":"335","author":"A Repaci","year":"2010","unstructured":"Repaci A, Gambineri A, Pasquali R (2010) The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 335:30\u201341","journal-title":"Mol Cell Endocrinol"},{"key":"215_CR33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","volume":"69","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"Diamanti-Kandarakis E, Katsikis I, Piperi C et al (2008) Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 69:634\u2013641","journal-title":"Clin Endocrinol (Oxf)"},{"key":"215_CR34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.rbmo.2009.05.012","volume":"19","author":"S Guven","year":"2009","unstructured":"Guven S, Karahan SC, Bayram C, Ucar U, Ozeren M (2009) Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease. Reprod Biomed Online 19:493\u2013500","journal-title":"Reprod Biomed Online"},{"key":"215_CR35","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","volume":"89","author":"EO Talbott","year":"2004","unstructured":"Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS (2004) Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:5454\u20135461","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR36","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1210\/jc.2007-1343","volume":"92","author":"R Shroff","year":"2007","unstructured":"Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A (2007) Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 92:4609\u20134614","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR37","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","volume":"90","author":"M Kravariti","year":"2005","unstructured":"Kravariti M, Naka KK, Kalantaridou SN et al (2005) Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:5088\u20135095","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR38","first-page":"561","volume":"5","author":"MM Ciccone","year":"2009","unstructured":"Ciccone MM, Favale S, Bhuva A et al (2009) Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome. Vasc Health Risk Manag 5:561\u2013566","journal-title":"Vasc Health Risk Manag"},{"key":"215_CR39","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2012-1597","volume":"97","author":"ET Wang","year":"2012","unstructured":"Wang ET, Ku IA, Shah SJ et al (2012) Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women\u2019s study. J Clin Endocrinol Metab 97:4656\u20134662","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2012.11.004","volume":"226","author":"E Cakir","year":"2013","unstructured":"Cakir E, Dogan M, Topaloglu O et al (2013) Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism. Atherosclerosis 226:291\u2013295","journal-title":"Atherosclerosis"},{"key":"215_CR41","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/jcem.87.5.8456","volume":"87","author":"E Charmandari","year":"2002","unstructured":"Charmandari E, Weise M, Bornstein SR et al (2002) Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 87:2114\u20132120","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR42","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","volume":"95","author":"W Arlt","year":"2010","unstructured":"Arlt W, Willis DS, Wild SH et al (2010) Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 95:5110\u20135121","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR43","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","volume":"61","author":"T Mancini","year":"2004","unstructured":"Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G (2004) High cardiovascular risk in patients with Cushing\u2019s syndrome according to 1999 WHO\/ISH guidelines. Clin Endocrinol (Oxf) 61:768\u2013777","journal-title":"Clin Endocrinol (Oxf)"},{"key":"215_CR44","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1210\/jc.2006-1069","volume":"91","author":"TM Volkl","year":"2006","unstructured":"Volkl TM, Simm D, Dotsch J, Rascher W, Dorr HG (2006) Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4888\u20134895","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40618-014-0148-8","volume":"37","author":"NH Amr","year":"2014","unstructured":"Amr NH, Ahmed AY, Ibrahim YA (2014) Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia. J Endocrinol Invest 37:1001\u20131008","journal-title":"J Endocrinol Invest"},{"key":"215_CR46","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/meta.2000.6261","volume":"49","author":"D Botero","year":"2000","unstructured":"Botero D, Arango A, Danon M, Lifshitz F (2000) Lipid profile in congenital adrenal hyperplasia. Metabolism 49:790\u2013793","journal-title":"Metabolism"},{"key":"215_CR47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000313368","volume":"74","author":"A Zimmermann","year":"2010","unstructured":"Zimmermann A, Grigorescu-Sido P, AlKhzouz C et al (2010) Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr 74:41\u201349","journal-title":"Horm Res Paediatr"},{"key":"215_CR48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1210\/jc.2006-1350","volume":"92","author":"H Falhammar","year":"2007","unstructured":"Falhammar H, Filipsson H, Holmdahl G et al (2007) Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:110\u2013116","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR49","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2265.2011.04309.x","volume":"76","author":"J Harrington","year":"2012","unstructured":"Harrington J, Pena AS, Gent R, Hirte C, Couper J (2012) Adolescents with congenital adrenal hyperplasia because of 21-hydroxylase deficiency have vascular dysfunction. Clin Endocrinol (Oxf) 76:837\u2013842","journal-title":"Clin Endocrinol (Oxf)"},{"key":"215_CR50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2362.2011.02550.x","volume":"42","author":"K Unluhizarci","year":"2012","unstructured":"Unluhizarci K, Kaltsas G, Kelestimur F (2012) Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Invest 42:86\u201394","journal-title":"Eur J Clin Invest"},{"key":"215_CR51","doi-asserted-by":"crossref","first-page":"593197","DOI":"10.1155\/2013\/593197","volume":"2013","author":"A Talaei","year":"2013","unstructured":"Talaei A, Adgi Z, Mohamadi Kelishadi M (2013) Idiopathic hirsutism and insulin resistance. Int J Endocrinol 2013:593197","journal-title":"Int J Endocrinol"},{"key":"215_CR52","first-page":"1889","volume":"18","author":"M Erkan","year":"2014","unstructured":"Erkan M, Albayrak M, Karatas A et al (2014) Are insulin resistance and serum resistin levels increased in women with idiopathic hirsutism? Eur Rev Med Pharmacol Sci 18:1889\u20131895","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"215_CR53","first-page":"161","volume":"18","author":"RH Young","year":"2001","unstructured":"Young RH, Scully RE (2001) Differential diagnosis of ovarian tumors based primarily on their patterns and cell types. Semin Diagn Pathol 18:161\u2013235","journal-title":"Semin Diagn Pathol"},{"key":"215_CR54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2012.04438.x","volume":"78","author":"C Pelusi","year":"2013","unstructured":"Pelusi C, Forlani G, Zanotti L, Gambineri A, Pasquali R (2013) No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours. Clin Endocrinol (Oxf) 78:533\u2013538","journal-title":"Clin Endocrinol (Oxf)"},{"key":"215_CR55","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jcem.83.8.5041","volume":"83","author":"E Diamanti-Kandarakis","year":"1998","unstructured":"Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G, Duleba AJ (1998) The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol Metab 83:2699\u20132705","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-10-0709","volume":"164","author":"KB Studen","year":"2011","unstructured":"Studen KB, Sebestjen M, Pfeifer M, Prezelj J (2011) Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome. Eur J Endocrinol 164:389\u2013395","journal-title":"Eur J Endocrinol"},{"key":"215_CR57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/09513590.2010.521265","volume":"27","author":"KK Naka","year":"2011","unstructured":"Naka KK, Kalantaridou SN, Bechlioulis A et al (2011) Effect of ethinylestradiol\/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study. Gynecol Endocrinol 27:615\u2013621","journal-title":"Gynecol Endocrinol"},{"key":"215_CR58","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2010-2547","volume":"96","author":"H Tfayli","year":"2011","unstructured":"Tfayli H, Ulnach JW, Lee S, Sutton-Tyrrell K, Arslanian S (2011) Drospirenone\/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors. J Clin Endocrinol Metab 96:1311\u20131319","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.contraception.2011.12.011","volume":"86","author":"CS Vieira","year":"2012","unstructured":"Vieira CS, Martins WP, Fernandes JB et al (2012) The effects of 2\u00a0mg chlormadinone acetate\/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception 86:268\u2013275","journal-title":"Contraception"},{"key":"215_CR60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","volume":"77","author":"G Mastorakos","year":"2002","unstructured":"Mastorakos G, Koliopoulos C, Creatsas G (2002) Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril 77:919\u2013927","journal-title":"Fertil Steril"},{"key":"215_CR61","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2265.2012.04415.x","volume":"78","author":"N Cinar","year":"2013","unstructured":"Cinar N, Harmanci A, Bayraktar M, Yildiz BO (2013) Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 78:379\u2013384","journal-title":"Clin Endocrinol (Oxf)"},{"key":"215_CR62","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fertnstert.2006.01.009","volume":"85","author":"CN Merz","year":"2006","unstructured":"Merz CN, Johnson BD, Berga S, Braunstein G, Reis SE, Bittner V (2006) Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women\u2019s Ischemia Syndrome Evaluation. Fertil Steril 85:1425\u20131431","journal-title":"Fertil Steril"},{"key":"215_CR63","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1503\/cmaj.120677","volume":"185","author":"ST Bird","year":"2013","unstructured":"Bird ST, Hartzema AG, Brophy JM, Etminan M, Delaney JA (2013) Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ 185:E115\u2013E120","journal-title":"CMAJ"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0215-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0215-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0215-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:03:38Z","timestamp":1559502218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0215-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,29]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0215-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,29]]}}}